Forward-Looking Statement

The information in this site contains forward-looking statements, including without limitation, statements concerning clinical trial strategies, planned clinical trials and activities and anticipated timing of clinical events, potential partnering activities, product development objectives, potential advantages of Vericel’s technology and expanded autologous cellular therapies and products, and potential product applications, which involve certain risks and uncertainties.

Actual results may differ significantly from the expectations contained in the forward-looking statements. Among the factors that may result in differences are the results obtained from clinical trials and development activities, regulatory approval requirements, competitive conditions and the availability of financial and other resources and the allocation of resources among different potential uses. These and other significant factors are discussed in greater detail on Vericel’s Annual Report on Form 10-K, and other filings with the Securities and Exchange Commission, which are available at